Uniphage is a biotech company that eliminates bacterial infections by combining the power of bacteriophages with artificial intelligence.
Uniphage has raised $256K in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Uniphage's investors include National Science Foundation, MassChallenge.
Uniphage is headquartered in San Francisco, United States.
Uniphage is a biotech company that eliminates bacterial infections by combining the power of bacteriophages with artificial intelligence.
Uniphage is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Uniphage — Funding & Investors." VCBacked, April 11, 2022, https://www.vcbacked.co/company/uniphage. Accessed October 30, 2026.
VCBacked. (2022). Uniphage — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/uniphage
{{cite web |title=Uniphage — Funding & Investors |url=https://www.vcbacked.co/company/uniphage |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated